388 related articles for article (PubMed ID: 32016907)
1. Hypokalemia and hyperkalemia in patients on peritoneal dialysis: incidence and associated factors.
Goncalves FA; de Jesus JS; Cordeiro L; Piraciaba MCT; de Araujo LKRP; Steller Wagner Martins C; Dalboni MA; Pereira BJ; Silva BC; Moysés RMA; Abensur H; Elias RM
Int Urol Nephrol; 2020 Feb; 52(2):393-398. PubMed ID: 32016907
[TBL] [Abstract][Full Text] [Related]
2. Hyperkalemia in chronic peritoneal dialysis patients.
Elliott AB; Soliman KMM; Ullian ME
Ren Fail; 2022 Dec; 44(1):217-223. PubMed ID: 35166182
[No Abstract] [Full Text] [Related]
3. Racial and Ethnic Differences in Mortality Associated with Serum Potassium in Incident Peritoneal Dialysis Patients.
Eriguchi R; Obi Y; Soohoo M; Rhee CM; Kovesdy CP; Kalantar-Zadeh K; Streja E
Am J Nephrol; 2019; 50(5):361-369. PubMed ID: 31522173
[TBL] [Abstract][Full Text] [Related]
4. Impact of Renin-Angiotensin Aldosterone System Inhibition on Serum Potassium Levels among Peritoneal Dialysis Patients.
Ribeiro SC; Figueiredo AE; Barretti P; Pecoits-Filho R; de Moraes TP;
Am J Nephrol; 2017; 46(2):150-155. PubMed ID: 28738355
[TBL] [Abstract][Full Text] [Related]
5. Dyskalemia, its patterns, and prognosis among patients with incident heart failure: A nationwide study of US veterans.
Matsushita K; Sang Y; Yang C; Ballew SH; Grams ME; Coresh J; Molnar MZ
PLoS One; 2019; 14(8):e0219899. PubMed ID: 31393910
[TBL] [Abstract][Full Text] [Related]
6. Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system.
Nilsson E; Gasparini A; Ärnlöv J; Xu H; Henriksson KM; Coresh J; Grams ME; Carrero JJ
Int J Cardiol; 2017 Oct; 245():277-284. PubMed ID: 28735756
[TBL] [Abstract][Full Text] [Related]
7. Incident Hyperkalemia, Hypokalemia, and Clinical Outcomes During Spironolactone Treatment of Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT Trial.
Desai AS; Liu J; Pfeffer MA; Claggett B; Fleg J; Lewis EF; McKinlay S; O'Meara E; Shah SJ; Sweitzer NK; Solomon S; Pitt B
J Card Fail; 2018 May; 24(5):313-320. PubMed ID: 29572190
[TBL] [Abstract][Full Text] [Related]
8. Association between serum potassium levels and adverse outcomes in chronic kidney disease: the Fukushima CKD cohort study.
Tanaka K; Saito H; Iwasaki T; Oda A; Watanabe S; Kanno M; Kimura H; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
Clin Exp Nephrol; 2021 Apr; 25(4):410-417. PubMed ID: 33411113
[TBL] [Abstract][Full Text] [Related]
9. Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.
Nakhoul GN; Huang H; Arrigain S; Jolly SE; Schold JD; Nally JV; Navaneethan SD
Am J Nephrol; 2015; 41(6):456-63. PubMed ID: 26228532
[TBL] [Abstract][Full Text] [Related]
10. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
[TBL] [Abstract][Full Text] [Related]
11. Serum potassium in stage 5 CKD patients on their first presentation in a dialysis service of a county hospital in western Romania.
Gluhovschi G; Mateş A; Gluhovschi C; Golea O; Gădălean F; Somai M; Ene I; Petrica L; Velciov S
Rom J Intern Med; 2014; 52(1):30-8. PubMed ID: 25000676
[TBL] [Abstract][Full Text] [Related]
12. Hyperkalemia and Hypokalemia in CKD: Prevalence, Risk Factors, and Clinical Outcomes.
Gilligan S; Raphael KL
Adv Chronic Kidney Dis; 2017 Sep; 24(5):315-318. PubMed ID: 29031358
[TBL] [Abstract][Full Text] [Related]
13. Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist.
Vardeny O; Claggett B; Anand I; Rossignol P; Desai AS; Zannad F; Pitt B; Solomon SD;
Circ Heart Fail; 2014 Jul; 7(4):573-9. PubMed ID: 24812304
[TBL] [Abstract][Full Text] [Related]
14. Hypokalemia in Chinese peritoneal dialysis patients: prevalence and prognostic implication.
Szeto CC; Chow KM; Kwan BC; Leung CB; Chung KY; Law MC; Li PK
Am J Kidney Dis; 2005 Jul; 46(1):128-35. PubMed ID: 15983966
[TBL] [Abstract][Full Text] [Related]
15. Use of Renin-Angiotensin System Blockers Increases Serum Potassium in Anuric Hemodialysis Patients.
Movilli E; Camerini C; Gaggia P; Zubani R; Cancarini G
Am J Nephrol; 2018; 48(2):79-86. PubMed ID: 30071530
[TBL] [Abstract][Full Text] [Related]
16. Association of hypo- and hyperkalemia with disease progression and mortality in males with chronic kidney disease: the role of race.
Hayes J; Kalantar-Zadeh K; Lu JL; Turban S; Anderson JE; Kovesdy CP
Nephron Clin Pract; 2012; 120(1):c8-16. PubMed ID: 22156587
[TBL] [Abstract][Full Text] [Related]
17. Dyskalemias and adverse events associated with discharge potassium in acute myocardial infarction.
Xu H; Faxén J; Szummer K; Trevisan M; Kovesdy CP; Jernberg T; Carrero JJ
Am Heart J; 2018 Nov; 205():53-62. PubMed ID: 30170177
[TBL] [Abstract][Full Text] [Related]
18. Potassium disorders in pediatric emergency department: Clinical spectrum and management.
Barbance O; De Bels D; Honoré PM; Bargalzan D; Tolwani A; Ismaili K; Biarent D; Redant S
Arch Pediatr; 2020 Apr; 27(3):146-151. PubMed ID: 31955956
[TBL] [Abstract][Full Text] [Related]
19. Influence of dyskalemia at admission and early dyskalemia correction on survival and cardiac events of critically ill patients.
Bouadma L; Mankikian S; Darmon M; Argaud L; Vinclair C; Siami S; Garrouste-Orgeas M; Papazian L; Cohen Y; Marcotte G; Styfalova L; Reignier J; Lautrette A; Schwebel C; Timsit JF;
Crit Care; 2019 Dec; 23(1):415. PubMed ID: 31856891
[TBL] [Abstract][Full Text] [Related]
20. Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on serum potassium levels and renal function in ambulatory outpatients: risk factors analysis.
Maddirala S; Khan A; Vincent A; Lau K
Am J Med Sci; 2008 Oct; 336(4):330-5. PubMed ID: 18854676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
